Weilheim-Unterhausen, Germany

Werner Zolg




Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Weilhelm-Unterhausen, DE (2007)
  • Weilheim, DE (2009)
  • Weilheim-Unterhausen, DE (2009 - 2011)

Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Mind of Werner Zolg

Introduction

Werner Zolg, a prominent inventor based in Weilheim-Unterhausen, Germany, has made significant strides in the field of medical diagnostics. With a total of seven patents to his name, his innovative approaches are redefining how rheumatoid arthritis is assessed and diagnosed. His work emphasizes the importance of combining various biomarkers to provide a comprehensive analysis of this chronic condition.

Latest Patents

Among Werner Zolg's latest patents is a groundbreaking method to assess the severity of rheumatoid arthritis by measuring anti-CCP and serum amyloid A. This method involves analyzing a patient sample for the concentrations of anti-cyclic citrullinated peptides (anti-CCP) and serum amyloid A, which are then combined to produce a value that can be compared to a cut-off value derived from a reference population. Additionally, this patent outlines the inclusion of other markers, such as C-reactive protein (CRP), interleukin 6 (IL-6), and matrix metalloproteases, to enhance the diagnostic process. Another patent focuses on the combined measurement of anti-CCP and serum amyloid A, aiding in the in vitro assessment of rheumatoid arthritis through thorough biochemical analysis, determining the presence or absence of the disease.

Career Highlights

Werner Zolg currently works at Roche Diagnostics Operations, Inc., where his expertise and innovative spirit have contributed to groundbreaking advancements in medical technology. His intellectual contributions have not only enhanced the diagnostic capabilities for rheumatoid arthritis but have also led to more effective treatment plans for patients suffering from this debilitating condition.

Collaborations

Throughout his career, Zolg has collaborated with esteemed professionals in the field, including Johann Karl and Herbert Andres. These partnerships have fostered a productive environment for innovation and have supported the development of valuable medical diagnostics and solutions.

Conclusion

Werner Zolg exemplifies the essence of innovation in the medical field, particularly in the realm of rheumatology. His patents demonstrate a deep understanding of the complexities of rheumatoid arthritis and reflect his commitment to improving patient care through advanced diagnostic methods. As he continues to contribute to this vital area of research, the impact of his work will undoubtedly resonate in the healthcare community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…